In this paper, we demonstrated the efficacy of the PDIA3 inhibitor in terms of its cytotoxicity effects in two cellular models of glioblastoma, T98G and U-87 MG cell lines; based on the data obtained, the antiproliferative effects induced by PDIA3 inhibition were related to an increase in DNA damage. Here, PDIA3 is linked to glioblastoma.